𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer

✍ Scribed by Stewart, HJ; Forrest, AP; Everington, D; McDonald, CC; Dewar, JA; Hawkins, RA; Prescott, RJ; George, WD

Book ID
109837270
Publisher
Nature Publishing Group
Year
1996
Tongue
English
Weight
429 KB
Volume
74
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of switching to exeme
Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer
✍ Nancy A. Risebrough; Shailendra Verma; Maureen Trudeau; Nicole Mittmann 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract ## BACKGROUND. Sequential tamoxifen/exemestane therapy reportedly improves disease‐free survival in women with primary breast cancer compared with continued tamoxifen therapy. The objective of the current study was to assess the cost‐effectiveness of switching to exemestane after 2 to

Tumour excision plus continuous tamoxife
Tumour excision plus continuous tamoxifen compared with modified radical mastectomy in patients over 70 years of age with operable breast cancer
✍ Prof. Jacobus Alwyn Van Zyl; Anna Gertruida S. Muller 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

## Abstract Between 1985 and 1991, we randomly assigned 77 women over the age of 70 years with stage I‐3a breast cancer to undergo a modified radical mastectomy or tumour excision followed by tamoxifen. Median follow‐up was 45 months. Patients treated by tumour excision and tamoxifen had a signifi